• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » CoreMap gains $10.5M in Series A round

CoreMap gains $10.5M in Series A round

September 17, 2020 By Nancy Crotti

Burlington, Vt.-based startup CoreMap has secured $10.5 million in a Series A funding round led by Qure Ventures.

Founded in 2016, CoreMap is taking aim at atrial fibrillation (AF) with technology designed to map complex arrhythmias inside the heart. The company’s patented system combines an electrode pair design in a high-density array configuration with algorithm-driven mapping and visualization software to help electrophysiologists make more informed therapeutic decisions and improve patient outcomes.

The Series A round included both existing investors such as Dr. Ronny Ginor of Fifth Focus/HRMG  Investments and Orbimed Venture Partners. The funds will be used to accelerate CoreMap’s product development and regulatory submission for its first products.

“CoreMap’s inventions have broad potential for biological sensing which in turn may unlock patient-specific treatment for the millions of people suffering with persistent AF issues,” Ginor said in a news release.

“We are building a group of smart, hardworking, innovative, people committed to delivering a cure
for AF,” said CoreMap CEO and co-founder Sarah Kalil. “Having the financial support and domain expertise of the health tech pioneers that are resident in our investor group will allow us to better execute on our vision and change lives.”

CoreMap also recently won a National Science Foundation Phase I SBIR grant to support development of its technology. And it was a 2019 member of the MedTech Ignite Growth Challenge Cohort assembled by the Massachusetts Medical Device Industry Council (MassMEDIC) virtual accelerator program, which relaunched last year.

“We congratulate Sarah Kalil and her team at CoreMap on the financing,” said MassMEDIC president Brian Johnson in a separate statement. “CoreMap is the first Ignite founder to secure a Series A round but will surely not be the last.”

Kalil now serves on the board of RBI Medical, an Ignite 2020 cohort member company.

“MassMEDIC Ignite helped us in many ways and we are grateful to have participated in the first year of the program’s relaunch,” Kalil said. “Thanks to Ignite, we honed our pitch, received great counsel on financial, legal and regulatory issues—and perhaps most importantly, Ignite provided CoreMap national exposure and introductions to a well-connected support network.”

Filed Under: Business/Financial News, Cardiovascular, Featured, Funding Roundup Tagged With: CoreMap, FifthFocus/HRMG Investments, MassMEDIC, OrbiMed, Qure Ventures

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy